CD8A and neoplasm: Our previous experiments indicate that MATE-expressing virotherapy led to an enhanced infiltration of CD8+ T cells within the tumor and promotes PD1 expression suggesting that MATE-expressing virotherapy could be a promising intervention prior to application of checkpoint inhibitors.